KP
HCA icon

Kiltearn Partners’s HCA Healthcare HCA Stock Holding History

Kiltearn Partners’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
37,314
+7,314
+24% +$3.09M 3.53% 9
2026
Q1 		$14.2M Sell
30,000
-5,800
-16% -$2.92M 3.82% 11
2025
Q4 		$16.7M Sell
35,800
-6,900
-16% -$3.2M 3.62% 10
2025
Q3 		$18.2M Buy
42,700
+3,200
+8% +$1.24M 3.65% 9
2025
Q2 		$15.1M Sell
39,500
-3,200
-7% -$1.15M 3.04% 11
2025
Q1 		$14.8M Sell
42,700
-7,000
-14% -$2.25M 2.81% 13
2024
Q4 		$14.9M Sell
49,700
-5,100
-9% -$1.78M 2.46% 16
2024
Q3 		$22.3M Sell
54,800
-33,300
-38% -$12.2M 3.03% 13
2024
Q2 		$28.3M Sell
88,100
-51,900
-37% -$16.9M 3.43% 12
2024
Q1 		$46.2M Sell
140,000
-32,300
-19% -$9.87M 4.27% 9
2023
Q4 		$46.6M Buy
172,300
+24,600
+17% +$6.08M 3.59% 13
2023
Q3 		$36.3M Sell
147,700
-5,500
-4% -$1.5M 2.87% 14
2023
Q2 		$46.5M Sell
153,200
-4,300
-3% -$1.2M 3.4% 14
2023
Q1 		$41.5M Buy
157,500
+27,100
+21% +$6.88M 3% 17
2022
Q4 		$31.3M Buy
+130,400
New +$29.2M 2.3% 22

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kiltearn Partners's HCA Position: Q2 2026 in Review

Kiltearn Partners increased its HCA Healthcare (HCA) stake by 24% in Q2 2026, buying an estimated $3.09M and bringing the position to 37,314 shares worth $14.5M. The position accounts for 3.53% of the portfolio, ranked #9.

Kiltearn Partners first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $46.6M in Q4 2023. 1,337 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Kiltearn Partners held 37,314 shares of HCA Healthcare worth $14.5M as of Q2 2026.
  • Kiltearn Partners bought 7,314 HCA Healthcare shares in Q2 2026, an estimated $3.09M.
  • HCA Healthcare made up 3.53% of Kiltearn Partners's portfolio in Q2 2026, its #9 holding.
  • Kiltearn Partners first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Kiltearn Partners's HCA Healthcare position peaked at $46.6M in Q4 2023.
  • 1,337 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Kiltearn Partners's 13F filing for Q2 2026, filed 12 Aug 2026.